ABSTRACT
Purpose The SmartSleep Study is established to comprehensively assess the impact of night-time smartphone use on sleep patterns and health. An innovative combination of large-scale repeated survey information, high-resolution sensor-driven smartphone data, in-depth clinical examination and registry linkage allow for detailed investigations into multisystem physiological dysregulation and long-term health consequences associated with night-time smartphone use and sleep impairment.
Participants The SmartSleep Study consists of three interconnected data samples, which combined include 30,673 individuals with information on smartphone use, sleep and health. Subsamples of the study population also include high-resolution tracking data (n=5,927) collected via a customized app and deep clinical phenotypic data (n=245). A total of 7,208 participants will be followed in nationwide health registries with full data coverage and long-term follow-up.
Findings to date We highlight previous findings on the relation between smartphone use and sleep in the SmartSleep Study, and we evaluate the interventional potential of the citizen science approach used in one of the data samples. We also present new results from an analysis in which we utilize 803,000 data-points from the high-resolution tracking data to identify clusters of temporal trajectories of night-time smartphone use that characterize distinct use patterns. Based on these objective tracking data, we characterize four clusters of night-time smartphone use.
Future plans The unprecedented size and coverage of the SmartSleep Study allow for a comprehensive documentation of smartphone activity during the entire sleep span. The study will be expanded by linkage to nationwide registers, which will allow for further investigations into the long-term health and social consequences of night-time smartphone use. We also plan new rounds of data collection in the coming years.
STRENGTHS and LIMITATIONS of this study
The unprecedented size and coverage of the SmartSleep Study allow for a comprehensive objective and subjective documentation of smartphone activity during the entire sleep span.
The data in the SmartSleep Study are sampled by three different strategies, which allow us to test robustness and validate findings across samples. This aligns with the principles of triangulation, which aims at obtaining more reliable answers to complex research questions through the integration of results from different approaches with different sources of bias.
The SmartSleep Study is readily available for research projects: the data sources have already been linked, the data have been cleaned and prepared for future analyses.
The SmartSleep Study is not fully representative of the general population due to the sampling procedures, and we are currently creating weights that can be used in the statistical analysis to compensate for this imbalance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The SmartSleep Study is funded by a Sapere Aude grant from the Independent Research Fund Denmark (grant number 7025-00005B), Helsefonden (grant number 20-B-0254) and the Velliv Association (grant number grant number 20-0047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data collections in the SmartSleep Study have been approved under the University of Copenhagen umbrella approval from the Danish Data Protection Agency (datatilsynet.dk), which ensures compliance with national and EU legislation in terms of data security (Citizen Science Sample no. 514-0237/18-3000 and 514-0288/19-3000 (2nd follow-up), Population sample no. 514-0288/19-3000 and Clinical Sample no. 514-0344/19-3000). The data collection for the Clinical Sample was further approved by the National Committee on Health Research Ethics (approval no. 67074). Participation in all parts of the study was voluntary and the participants gave informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos